PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1213.73%
Net income growth above 1.5x CRK's 101.06%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
6.11%
Some D&A expansion while CRK is negative at -78.22%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
292.46%
Some yoy growth while CRK is negative at -35.00%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-41.66%
Negative yoy working capital usage while CRK is 160.57%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-41.66%
Negative yoy usage while CRK is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-72.45%
Both negative yoy, with CRK at -239.40%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
13.66%
Some CFO growth while CRK is negative at -43.10%. John Neff would note a short-term liquidity lead over the competitor.
-4.79%
Negative yoy CapEx while CRK is 74.56%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-100.00%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-113.63%
We reduce yoy other investing while CRK is 1034354.55%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-32.86%
We reduce yoy invests while CRK stands at 174.19%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
Debt repayment growth of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-79.29%
Negative yoy issuance while CRK is 56.40%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
95.12%
Similar buyback growth to CRK's 100.00%. Walter Schloss sees parallel capital return priorities or a stable free cash flow for both.